The North American Cysticercosis Consortium was formed in 2009 to promote collaboration and sharing of resources in the study of neurocysticercosis among clinicians and research scientists in North America. An estimated 1,500 cases of neurocysticercosis are diagnosed each year in the United States.
Main Areas of Focus
- To further the study and rational treatment of neurocysticercosis in North America
- To determine the feasibility of conducting collaborative, multicenter studies of neurocysticercosis
- To pool the experience of practitioners in North America who are involved in the management of this disease
Content last reviewed on